MedTrace Logo

Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors

NCT00954564 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 351

Last updated 2017-04-04

No results posted yet for this study

Summary

RATIONALE: Gathering information over time about joint pain and stiffness from postmenopausal women with early-stage breast cancer who are receiving aromatase inhibitors may help doctors plan treatment and help patients live more comfortably.

PURPOSE: This observational epidemiologic cohort is designed to study arthralgia, patient-reported outcomes, and medication adherence in postmenopausal women with early-stage breast cancer who are receiving aromatase inhibitors.

Conditions

Interventions

OTHER

aromatase inhibition therapy - OBSERVATIONAL ONLY

Observational only - as prescribed

OTHER

medical chart review

Observational only

OTHER

questionnaire administration

Observational only

PROCEDURE

assessment of therapy complications

Observational only

Sponsors & Collaborators

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • American Cancer Society, Inc.

    collaborator OTHER

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Liana Castel, PhD, MSPH · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
35 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00954564 on ClinicalTrials.gov